{"database": "lobbying", "table": "lobbying_filings_raw", "rows": [["5dfd0530-8a0b-4713-9d2e-b86105d8a8a8", "Q3", 5073, "DALRYMPLE & ASSOCIATES, LLC", 105002, "DISCOVERY LABORATORIES", 2011, "third_quarter", "2011-10-07T14:40:34.010000-04:00", 20000.0, 0, 0, 0, "{\"url\": \"https://lda.senate.gov/api/v1/filings/5dfd0530-8a0b-4713-9d2e-b86105d8a8a8/\", \"filing_uuid\": \"5dfd0530-8a0b-4713-9d2e-b86105d8a8a8\", \"filing_type\": \"Q3\", \"filing_type_display\": \"3rd Quarter - Report\", \"filing_year\": 2011, \"filing_period\": \"third_quarter\", \"filing_period_display\": \"3rd Quarter (July 1 - Sep 30)\", \"filing_document_url\": \"https://lda.senate.gov/filings/public/filing/5dfd0530-8a0b-4713-9d2e-b86105d8a8a8/print/\", \"filing_document_content_type\": \"text/html\", \"income\": \"20000.00\", \"expenses\": null, \"expenses_method\": null, \"expenses_method_display\": null, \"posted_by_name\": \"Donald \\\"Dack\\\" Dalrymple, Principal\", \"dt_posted\": \"2011-10-07T14:40:34.010000-04:00\", \"termination_date\": null, \"registrant_country\": \"United States of America\", \"registrant_ppb_country\": null, \"registrant_address_1\": \"1926 N STREET NW\", \"registrant_address_2\": null, \"registrant_different_address\": false, \"registrant_city\": \"WASHINGTON\", \"registrant_state\": \"DC\", \"registrant_zip\": \"20036\", \"registrant\": {\"id\": 5073, \"url\": \"https://lda.senate.gov/api/v1/registrants/5073/\", \"house_registrant_id\": 34019, \"name\": \"DALRYMPLE & ASSOCIATES, LLC\", \"description\": \"Business Consulting\", \"address_1\": \"1926 N Street, NW\", \"address_2\": \"Suite 1\", \"address_3\": null, \"address_4\": null, \"city\": \"Washington\", \"state\": \"DC\", \"state_display\": \"District of Columbia\", \"zip\": \"20036\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"contact_name\": \"DONALD \\\"DACK\\\" DALRYMPLE\", \"contact_telephone\": \"+1 202-833-1043\", \"dt_updated\": \"2022-04-06T16:04:33.500584-04:00\"}, \"client\": {\"id\": 105002, \"url\": \"https://lda.senate.gov/api/v1/clients/105002/\", \"client_id\": 137, \"name\": \"DISCOVERY LABORATORIES\", \"general_description\": \"Biodefense & Civilian Drug Development\", \"client_government_entity\": false, \"client_self_select\": false, \"state\": \"PA\", \"state_display\": \"Pennsylvania\", \"country\": \"US\", \"country_display\": \"United States of America\", \"ppb_state\": null, \"ppb_state_display\": null, \"ppb_country\": \"US\", \"ppb_country_display\": \"United States of America\", \"effective_date\": \"2011-01-10\"}, \"lobbying_activities\": [{\"general_issue_code\": \"DEF\", \"general_issue_code_display\": \"Defense\", \"description\": \"Small peptide synthetic lung surfactant and delivery devices CBRN threat medical countermeasures research and development defense agency grant and contract funding opportunities, legislation, appropriations and oversight.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 46869, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"DONALD\", \"nickname\": \"DACK\", \"middle_name\": null, \"last_name\": \"DALRYMPLE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Principal\", \"new\": false}], \"government_entities\": [{\"id\": 30, \"name\": \"Army, Dept of (Other)\"}, {\"id\": 115, \"name\": \"Ballistic Missile Defense Organization\"}, {\"id\": 134, \"name\": \"Centers For Disease Control & Prevention (CDC)\"}, {\"id\": 25, \"name\": \"Defense, Dept of (DOD)\"}, {\"id\": 236, \"name\": \"Defense Threat Reduction Agency (DTRA)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 34, \"name\": \"Health & Human Services, Dept of (HHS)\"}, {\"id\": 201, \"name\": \"Homeland Security, Dept of (DHS)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 139, \"name\": \"Natl Institutes of Health (NIH)\"}, {\"id\": 1, \"name\": \"SENATE\"}, {\"id\": 12, \"name\": \"White House Office\"}]}, {\"general_issue_code\": \"HOM\", \"general_issue_code_display\": \"Homeland Security\", \"description\": \"Small peptide synthetic lung surfactant and delivery device medical countermeasures research and development agency grant and contract funding opportunities, legislation, appropriations, and oversight.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 46869, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"DONALD\", \"nickname\": \"DACK\", \"middle_name\": null, \"last_name\": \"DALRYMPLE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Principal\", \"new\": false}], \"government_entities\": [{\"id\": 30, \"name\": \"Army, Dept of (Other)\"}, {\"id\": 115, \"name\": \"Ballistic Missile Defense Organization\"}, {\"id\": 134, \"name\": \"Centers For Disease Control & Prevention (CDC)\"}, {\"id\": 25, \"name\": \"Defense, Dept of (DOD)\"}, {\"id\": 236, \"name\": \"Defense Threat Reduction Agency (DTRA)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 34, \"name\": \"Health & Human Services, Dept of (HHS)\"}, {\"id\": 201, \"name\": \"Homeland Security, Dept of (DHS)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 139, \"name\": \"Natl Institutes of Health (NIH)\"}, {\"id\": 1, \"name\": \"SENATE\"}, {\"id\": 12, \"name\": \"White House Office\"}]}, {\"general_issue_code\": \"MED\", \"general_issue_code_display\": \"Medical/Disease Research/Clinical Labs\", \"description\": \"Small peptide synthetic lung surfactant and medical device delivery medical countermeasures against CBRN threats research and development grant and contract funding opportunities, legislation, appropriations and oversight.\", \"foreign_entity_issues\": \"\", \"lobbyists\": [{\"lobbyist\": {\"id\": 46869, \"prefix\": \"mr\", \"prefix_display\": \"MR.\", \"first_name\": \"DONALD\", \"nickname\": \"DACK\", \"middle_name\": null, \"last_name\": \"DALRYMPLE\", \"suffix\": null, \"suffix_display\": null}, \"covered_position\": \"Principal\", \"new\": false}], \"government_entities\": [{\"id\": 30, \"name\": \"Army, Dept of (Other)\"}, {\"id\": 115, \"name\": \"Ballistic Missile Defense Organization\"}, {\"id\": 134, \"name\": \"Centers For Disease Control & Prevention (CDC)\"}, {\"id\": 25, \"name\": \"Defense, Dept of (DOD)\"}, {\"id\": 236, \"name\": \"Defense Threat Reduction Agency (DTRA)\"}, {\"id\": 135, \"name\": \"Food & Drug Administration (FDA)\"}, {\"id\": 34, \"name\": \"Health & Human Services, Dept of (HHS)\"}, {\"id\": 201, \"name\": \"Homeland Security, Dept of (DHS)\"}, {\"id\": 2, \"name\": \"HOUSE OF REPRESENTATIVES\"}, {\"id\": 139, \"name\": \"Natl Institutes of Health (NIH)\"}, {\"id\": 1, \"name\": \"SENATE\"}, {\"id\": 12, \"name\": \"White House Office\"}]}], \"conviction_disclosures\": [], \"foreign_entities\": [], \"affiliated_organizations\": []}"]], "columns": ["filing_uuid", "filing_type", "registrant_id", "registrant_name", "client_id", "client_name", "filing_year", "filing_period", "received_date", "amount_reported", "is_amendment", "is_no_activity", "is_termination", "raw_json"], "primary_keys": ["filing_uuid"], "primary_key_values": ["5dfd0530-8a0b-4713-9d2e-b86105d8a8a8"], "units": {}, "query_ms": 17.873766948468983, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}